Trade Summary

4 days ago, Powl Brian T., serving as Chief Commercial Officer at Kura Oncology, Inc. (KURA), sold 10,000 shares at $11.00 per share, for a total transaction value of $110,000.00. Following this transaction, Powl Brian T. now holds 173,614 shares of KURA.

This sale represents a 5.00% decrease in Powl Brian T.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 21, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 22, 2026 at 4:05 PM ET, 1 day after the trade was made.

Kura Oncology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.